Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply
In Reply Li et al commented on 2 issues pertaining to our analysis of hidradenitis suppurativa (HS) and mother-child health: a low prevalence of the exposure and potential residual confounding that decreased the impact and accuracy of the study.1
Authors
- Nathalie Auger (ORCID: https://orcid.org/0000-0002-2412-0459)
- Émilie Brousseau (ORCID: https://orcid.org/0009-0001-2455-7845)
- Kaiyang Li (ORCID: https://orcid.org/0000-0001-8557-166X)
Institutions
- McGill University Health Centre (CA)
- Institut National de Santé Publique du Québec (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1001/jamadermatol.2025.0503
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00